In addition, claudin-1 and claudin-2 were up-regulated in IBD-associated dysplasia and sporadic adenomas, as well as in colon carcinomas and metastatic lesions, suggesting their involvement in tumorigenesis and the invasiveness of colonic epithelial cells [38]. Here, CLDN2 is linked to inflammatory bowel disease.